Stevanato Group S.p.A. (NYSE: STVN)
Stevanato Group S.p.A. Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Stevanato Group S.p.A. Company Info
Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.
News & Analysis
No articles found.
Valuation
Earnings Transcripts
Stevanato Group S.p.A. (STVN) Q2 2022 Earnings Call Transcript
STVN earnings call for the period ending June 30, 2022.
Stevanato Group S.p.A. (STVN) Q1 2022 Earnings Call Transcript
STVN earnings call for the period ending March 31, 2022.
Stevanato Group S.p.A. (STVN) Q4 2021 Earnings Call Transcript
STVN earnings call for the period ending December 31, 2021.
Stevanato Group S.p.A. (STVN) Q3 2021 Earnings Call Transcript
STVN earnings call for the period ending September 30, 2021.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.